OptimizeRx (OPRX) Total Non-Current Liabilities (2010 - 2021)
OptimizeRx recorded quarterly Total Non-Current Liabilities of $260614.0 in Q3 2021, down 7.89% quarter-over-quarter from $282934.0 in Q2 2021, and down 26.92% year-over-year from $356618.0 in Q3 2020.
OptimizeRx's Total Non-Current Liabilities history runs 12 years deep, the most recent figure standing at $260614.0 for Q3 2021.
- In Q3 2021, Total Non-Current Liabilities fell 26.92% year-over-year to $260614.0; the TTM figure through Sep 2021 stood at $260614.0 (down 26.92% YoY), while the FY2020 annual figure was $325533.0, down 94.26% from the prior year.
- Total Non-Current Liabilities came in at $260614.0 for Q3 2021 at OptimizeRx, down from $282934.0 in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $5.7 million in Q4 2019 to a low of $260614.0 in Q3 2021.
- A 5-year average of $1.6 million and a median of $1.6 million in 2017 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities surged 512.12% in 2017 and slumped 94.26% in 2020, its largest moves.
- OptimizeRx's Total Non-Current Liabilities stood at $2.3 million in 2017, then climbed by 4.8% to $2.4 million in 2018, then surged by 139.69% to $5.7 million in 2019, then plunged by 94.26% to $325533.0 in 2020, then retreated by 19.94% to $260614.0 in 2021.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $260614.0, $282934.0, and $305039.0 for Q3 2021, Q2 2021, and Q1 2021 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 1.72 Bn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 4.20 Bn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 1.12 Bn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 172.85 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 1.90 Bn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 200.21 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 10.69 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 737.31 Mn |
| 10 | OptimizeRx | 101.31 Mn | 81.14 Mn | 15.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 260,614.00 |
| Jun 30, 2021 | 282,934.00 |
| Mar 31, 2021 | 305,039.00 |
| Dec 31, 2020 | 325,533.00 |
| Sep 30, 2020 | 356,618.00 |
| Jun 30, 2020 | 387,654.00 |
| Mar 31, 2020 | 3.14 Mn |
| Dec 31, 2019 | 5.67 Mn |
| Sep 30, 2019 | 2.01 Mn |
| Jun 30, 2019 | 2.05 Mn |
| Mar 31, 2019 | 1.96 Mn |
| Dec 31, 2018 | 2.37 Mn |
| Jun 30, 2018 | 1.56 Mn |
| Mar 31, 2018 | 1.15 Mn |
| Dec 31, 2017 | 2.26 Mn |
| Sep 30, 2017 | 1.47 Mn |
| Jun 30, 2017 | 1.71 Mn |
| Mar 31, 2017 | 1.57 Mn |
| Dec 31, 2016 | 1.37 Mn |
| Sep 30, 2016 | 926,193.00 |
| Jun 30, 2016 | 546,591.00 |
| Mar 31, 2016 | 256,792.00 |
| Dec 31, 2015 | 1.04 Mn |
| Sep 30, 2015 | 737,365.00 |
| Jun 30, 2015 | 125,947.00 |
| Mar 31, 2015 | 27,427.00 |
| Dec 31, 2014 | 265,427.00 |
| Sep 30, 2014 | -630,770.00 |
| Jun 30, 2014 | -1.67 Mn |
| Mar 31, 2014 | -1.24 Mn |
| Dec 31, 2013 | -15.86 Mn |
| Sep 30, 2013 | -17.56 Mn |
| Jun 30, 2013 | -19.35 Mn |
| Mar 31, 2013 | -19.31 Mn |
| Dec 31, 2012 | -19.29 Mn |
| Sep 30, 2012 | -19.94 Mn |
| Jun 30, 2012 | -19.80 Mn |
| Mar 31, 2012 | -19.88 Mn |
| Dec 31, 2011 | -19.52 Mn |
| Sep 30, 2011 | -20.09 Mn |
| Jun 30, 2011 | -18.42 Mn |
| Dec 31, 2010 | -18.43 Mn |